The FDA has released an announcement that they are investigating other drugs that contain trace amounts of NDMA, a known carcinogen. The release states that while non-US regulators have recalled drugs containing metformin, a common ingredient in blood-pressure-regulating medications for type 2 diabetics, the FDA is not issuing a recall and is still investigating. […]